HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre.

Abstract
There is a paucity of data regarding mixed mold pulmonary infections (MMPIs) in patients with haematological malignancies with or without haematopoietic stem cell transplantation (HSCT). We retrospectively studied 27 such patients (2005-2015) and compared them to patients with invasive pulmonary aspergillosis (IPA) caused by Aspergillus fumigatus. Factors associated with the diagnosis of MMPIs were significant corticosteroid use [20 (74%) vs 6 (22%), P < 0.001], sputum as the source specimen [13 (48%) vs 3 (11%), P = 0.003], younger age (median age: 58 vs 66 years, P = 0.006), and male sex [22 (81%) vs 13 (48%), P = 0.01]. Haematological cancers other than acute myeloid leukaemia (AML)/myelodysplastic syndromes (MDS) were less common in MMPIs than in IPA patients [AML/MDS: 6 (22%) vs 14 (52%), P = 0.04]. Only significant corticosteroid use [95% CI (2.7-42.7), P < 0.001], and sputum as the source specimen [95% (1.6-41.6), P = 0.012] were statistically significant as independently associated with increased risk of MMPIs diagnosis in multivariate analysis. Total mortality rate at day 42 postdiagnosis was comparable in both groups.
AuthorsEleni E Magira, Ying Jiang, Minas Economides, Jeffrey Tarrand, Dimitrios P Kontoyiannis
JournalMycoses (Mycoses) Vol. 61 Issue 11 Pg. 861-867 (Nov 2018) ISSN: 1439-0507 [Electronic] Germany
PMID30015364 (Publication Type: Journal Article)
Copyright© 2018 Blackwell Verlag GmbH.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aspergillus fumigatus (drug effects, genetics, isolation & purification, physiology)
  • Female
  • Hematologic Neoplasms (drug therapy, microbiology, surgery)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Invasive Pulmonary Aspergillosis (diagnosis, drug therapy, etiology, microbiology)
  • Male
  • Middle Aged
  • Postoperative Complications (diagnosis, drug therapy, etiology, microbiology)
  • Retrospective Studies
  • Tertiary Healthcare (statistics & numerical data)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: